WO1999012596A1 - Nozzle for use in mouth-inhaling for aerosol medicaments - Google Patents

Nozzle for use in mouth-inhaling for aerosol medicaments Download PDF

Info

Publication number
WO1999012596A1
WO1999012596A1 PCT/EP1998/005592 EP9805592W WO9912596A1 WO 1999012596 A1 WO1999012596 A1 WO 1999012596A1 EP 9805592 W EP9805592 W EP 9805592W WO 9912596 A1 WO9912596 A1 WO 9912596A1
Authority
WO
WIPO (PCT)
Prior art keywords
nozzle
aerosol
chamber
hole
stem
Prior art date
Application number
PCT/EP1998/005592
Other languages
French (fr)
Inventor
Paolo Chiesi
Marco Del Corno
Isabella Panza
Paolo Ventura
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to UA2000031257U priority Critical patent/UA1383U/en
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Priority to AU92661/98A priority patent/AU9266198A/en
Priority to ROA200000243A priority patent/RO120953B1/en
Priority to RU2000105401/20U priority patent/RU16905U1/en
Publication of WO1999012596A1 publication Critical patent/WO1999012596A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0086Inhalation chambers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0021Mouthpieces therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00Characteristics of a physical parameter; associated device therefor
    • A61M2206/10Flow characteristics
    • A61M2206/16Rotating swirling helical flow, e.g. by tangential inflows

Definitions

  • NOZZLE FOR USE IN MOUTH-IKHALIKG FOR AEROSOL MEDICAMENTS
  • the present invention relates to an aerosol nozzle, comprising a socket provided with a seat to house a hollow stem of an aerosol dispensing pressurized can.
  • Inhalation is the preferred system for delivering medicament particles into the lungs.
  • pressurized cans containing the medicament and a propellant are used, the cans being provided with a metering valve which when manually operated dispenses metered doses of propellant-medicament mixture which atomizes through a nozzle as a finely powdered spray into the mouth of a patient.
  • Said device is designed to favour the inhaling of a greater number of active particles and to avoid spraying the aerosol directly onto the mucosa of the oropharynx in order to safeguard the user against side effects deriving from direct spray into the mouth.
  • the device has an expansion chamber shaped to create, by virtue of the speed at which the aerosolized material is expelled by the dispenser, a vortex flow in which the particles remain in suspension for sufficient time to enable them to discharge their kinetic energy and allow substantial evaporation of the propellant, with a consequent reduction in the size and in the velocity of the particles, leading to a more efficient intrapulmonary delivery, while large size particles are centrifuged onto the walls of the chamber, to deposit on them.
  • the device comprises a body with a seat for housing a can provided with a stem for operating the can dispensing valve, a chamber for the collection and expansion of the aerosol dispensed by a discharge nozzle on the can, and a mouthpiece communicating with said chamber and projecting outwards from said body.
  • the body has a substantially flat shape and the chamber is delimited by a curved wall, into a first peripheral portion of which there opens the inner end of the mouthpiece, and in a second peripheral portions of which, opposite the first, there is an aperture from which two walls extend outwards from the chamber to converge towards the can discharge nozzle and define a duct, the central plane of which is inclined to the central plane of said mouthpiece.
  • Figure 1 is a perspective view of the inhaler device
  • Figure 2 shows one of the two shells forming the device, viewed in the direction indicated by the lines 2-2 of Figure 1
  • Figure 3 and 4 are sections through the inhaler device on the lines 3-3 and 4-4 of Figure 1.
  • an aerosol nozzle having the shape of a T consisting of an upper horizontal bar and a vertical stem, said stem comprising a socket with a seat for housing a hollow stem of a pressurized can, characterized in that the hole of the vertical stem of the nozzle through which a dose of medicament discharged from a metering valve finds its way into the expansion chamber is inclined with respect to the hollow stem of the pressurized can.
  • Figure 5 is a front view of the T shaped nozzle
  • Figure 6 is a side view of the T shaped nozzle
  • Figure 7 is a top view of the T shaped nozzle
  • Figure 8 is a section view of the nozzle along lines A-A of the Figures 5 and 7 , showing the socket provided with a seat to house a hollow stem of a pressurized can and the inclined hole through which a dose of medicament discharged from the valve enters into the expansion chamber .
  • the nozzle (1) is shaped as a T, consisting of an upper bar composed by two fins (2, 3) to be housed and retained in two seats provided in the two shells forming the device and of a vertical stem (4) shorter than the horizontal upper bar.
  • the vertical stem (4) comprises a socket (5) provided with a seat to house a hollow stem of a pressurized can.
  • the hole (6) is inclined with respect to the plane B normal to the axis of the vertical stem (4).
  • the discharged aerosol passes through the inclined hole (6) and emerges through the orifice (7) as a cone whose axis is inclined with respect to the plane B.
  • the axis of the hole and of the emerging aerosol cone forms with the plane B an angle in the range of 20 to 30° and preferably of 27°.
  • the internal diameter of the hole (6) is in the range of 0.40 to 0.55 mm and is preferably of 0.42 to 0.52 mm.
  • the inclination of the hole is designed in a manner that the aerosol cone issuing from the nozzle orifice passes through the duct defined by the two walls 11 and 21 of Figures 3 and 4 extending outwards from the expansion chamber and converging towards the exit hole of the nozzle.
  • the inclination of the hole is designed in a manner that the axis of said aerosol cone corresponds with the central plane of the ducts.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Nozzles (AREA)
  • Medicinal Preparation (AREA)

Abstract

An aerosol nozzle, comprising a socket provided with a seat to house a hollow stem of an aerosol dispensing pressurized can, said nozzle being shaped as a T, consisting of an upper bar and of a vertical stem, characterized in that the hole of said nozzle through which the aerosol dose is discharged is inclined with respect to the plane normal to the axis of said vertical stem.

Description

NOZZLE FOR USE IN MOUTH-IKHALIKG FOR AEROSOL MEDICAMENTS
The present invention relates to an aerosol nozzle, comprising a socket provided with a seat to house a hollow stem of an aerosol dispensing pressurized can.
Inhalation is the preferred system for delivering medicament particles into the lungs.
For this purpose pressurized cans containing the medicament and a propellant are used, the cans being provided with a metering valve which when manually operated dispenses metered doses of propellant-medicament mixture which atomizes through a nozzle as a finely powdered spray into the mouth of a patient.
It is generally known that only about 10% of the aerosol dose discharged by a pressurized can is capable to reach the lungs. A similar percentage is expired or is deposited outside the oral cavity, whereas because of the impact of the high speed particles about 80% is deposited within the oropharyngeal cavity, swallowed systemicallv adsorbed and hence practically lost.
If the pressurized can is not used properly the quantity of medicament which reaches the site of action at the pulmonary level is further reduced and the therapeutic response is compromised. Excessive aerosol depositing in the oropharyngeal cavity can also lead to undesirable effects either at systemic level as a consequence of the drug absorption, or at the local level, as in the case of corticosteroidε, which can result in oral candidiasis. The reasons for poor pulmonary penetration are known. Even if a dispensing can for aerosol medicaments is used correctly, the availability of an inhaled medicament to the lungs depends largely on the size of the aerosol droplets. The only particles that can penetrate into the lungs is any significant degree are those whose diameter is 1-5 thousandths of a millimetre (microns). An inhalation aerosol spray only contains a small amount of such particles as most of the medicament is bound to considerably larger droplets formed by a non-volatile propellant .
Thus, it is obvious that by reducing the droplet size of a spray it is also possible to reduce the particle size and hence to improve the pulmonary penetration of a medicament and the size of droplets is reduced as the volatilization of a propellant proceeds.
In an attempt to overcome the problems connected with the use of aerosol medicament, auxiliary delivery systems have been developed over the last decade for application to the nozzles of pressurized dispensing cans.
In the european patent EP-B-0475257 a mouth-inhaling device for use with pressurized cans for dispensing etered doses of medicament is described.
Said device is designed to favour the inhaling of a greater number of active particles and to avoid spraying the aerosol directly onto the mucosa of the oropharynx in order to safeguard the user against side effects deriving from direct spray into the mouth.
In this respect, the device has an expansion chamber shaped to create, by virtue of the speed at which the aerosolized material is expelled by the dispenser, a vortex flow in which the particles remain in suspension for sufficient time to enable them to discharge their kinetic energy and allow substantial evaporation of the propellant, with a consequent reduction in the size and in the velocity of the particles, leading to a more efficient intrapulmonary delivery, while large size particles are centrifuged onto the walls of the chamber, to deposit on them.
The device comprises a body with a seat for housing a can provided with a stem for operating the can dispensing valve, a chamber for the collection and expansion of the aerosol dispensed by a discharge nozzle on the can, and a mouthpiece communicating with said chamber and projecting outwards from said body. The body has a substantially flat shape and the chamber is delimited by a curved wall, into a first peripheral portion of which there opens the inner end of the mouthpiece, and in a second peripheral portions of which, opposite the first, there is an aperture from which two walls extend outwards from the chamber to converge towards the can discharge nozzle and define a duct, the central plane of which is inclined to the central plane of said mouthpiece.
The aerosol dispensed by the can, when operated, penetrates into the expansion chamber and expands to circulate with a vortex flow which causes the solvent to evaporate and the flow movement to continue for a relatively long time, hence enabling only very small particles of the medicament to be drawn into the bronchial tree. The structure and characteristics of the inhaler device are illustrated in Figure 1 to 4 in which: Figure 1 is a perspective view of the inhaler device; Figure 2 shows one of the two shells forming the device, viewed in the direction indicated by the lines 2-2 of Figure 1; and Figure 3 and 4 are sections through the inhaler device on the lines 3-3 and 4-4 of Figure 1.
It can be seen from Figure 2 that in a peripheral portion of the curved wall 10, opposite that from which the mouthpiece 4 projects, there is an aperture from which two walls 11 and 21, respectively (Figure 4), extend outwards from the chamber to converge (Figure 2) towards the exit hole of the nozzle and define a duct for the medicament flow.
It is now unexpectedly found that the aerosol circulation with a vortex flow into the expansion chamber can be favoured and improved by a particular realization of the nozzle wherein the hole through which the aerosol dose is discharged is inclined (Figure 8).
In accordance with the present invention there is provided an aerosol nozzle having the shape of a T consisting of an upper horizontal bar and a vertical stem, said stem comprising a socket with a seat for housing a hollow stem of a pressurized can, characterized in that the hole of the vertical stem of the nozzle through which a dose of medicament discharged from a metering valve finds its way into the expansion chamber is inclined with respect to the hollow stem of the pressurized can.
Specific embodiments of the invention will now be described, with reference to the accompanying drawings, in which:
Figure 5 is a front view of the T shaped nozzle; Figure 6 is a side view of the T shaped nozzle;
Figure 7 is a top view of the T shaped nozzle;
Figure 8 is a section view of the nozzle along lines A-A of the Figures 5 and 7 , showing the socket provided with a seat to house a hollow stem of a pressurized can and the inclined hole through which a dose of medicament discharged from the valve enters into the expansion chamber .
The nozzle (1) is shaped as a T, consisting of an upper bar composed by two fins (2, 3) to be housed and retained in two seats provided in the two shells forming the device and of a vertical stem (4) shorter than the horizontal upper bar.
The vertical stem (4) comprises a socket (5) provided with a seat to house a hollow stem of a pressurized can.
In the thickness of the stem (4) is bored a hole (6) that connects the socket (5) with the expansion chamber of the device through the orifice (7).
The hole (6) is inclined with respect to the plane B normal to the axis of the vertical stem (4).
When a pressurized can has been housed in the device, with the valve stem inserted into the seat of the socket
(5) of the nozzle (1) and the base of the can is pressed with one finger, the dispensing valve within the can opens and a measured quantity of aerosol is discharged.
The discharged aerosol passes through the inclined hole (6) and emerges through the orifice (7) as a cone whose axis is inclined with respect to the plane B.
The axis of the hole and of the emerging aerosol cone forms with the plane B an angle in the range of 20 to 30° and preferably of 27°. The internal diameter of the hole (6) is in the range of 0.40 to 0.55 mm and is preferably of 0.42 to 0.52 mm.
The inclination of the hole is designed in a manner that the aerosol cone issuing from the nozzle orifice passes through the duct defined by the two walls 11 and 21 of Figures 3 and 4 extending outwards from the expansion chamber and converging towards the exit hole of the nozzle.
The inclination of the hole is designed in a manner that the axis of said aerosol cone corresponds with the central plane of the ducts.
It is so avoided any possible deviation of the aerosol jet resulting from the impact of a part of the aerosol cone against the diverging walls 11 and 21. The aerosol cone penetrates into the expansion chamber and generates within the chamber a vortex motion which results in deposition of the largest particles on the walls whereas the other particles lose their layer of propellant and hence reduce in diameter with an increase of the respirable fraction.

Claims

1. An aerosol nozzle, comprising a socket provided with a seat to house a hollow stem of an aerosol dispensing pressurized can, said nozzle being shaped as a T, consisting of an upper bar and of a vertical stem, characterized in that the hole of said nozzle through which the aerosol dose is discharged is inclined with respect to the plane normal to the axis of said vertical stem.
2. A nozzle as claimed in claim 1, characterized in that the axis of the hole and the plane normal to the axis of the stem form an angle in the range of 20 to 30┬░ and preferably of 27┬░.
3. A nozzle as claimed in claims 1 and 2 wherein the internal diameter of the hole is in the range of 0.40 to 0.55 mm and preferably of 0.42 to 0.52 mm.
4. An aerosol nozzle substantially as herein described, with reference to, and as illustrated in, Fig.5 to 8 of the accompanying drawings.
5. A nozzle as claimed in claims 1 to 4 to be housed in a device for mouth inhaling medicaments dispensed as aerosols by pressurized cans, comprising a body with a seat for housing a can provided with a ste for operating the can dispensing valve, a chamber for the collection and expansion of the aerosol dispensed by a discharged nozzle of the can, and an inhalation mouthpieced communicating with said chamber and projecting outwards from said body, wherein the body is of substantially flat shape, che chamber si delimited by a curved wall, into a first peripheral portion of which there opens the inner end of said mouthpiece, and in a second peripheral portion of which, opposite the first, there is an aperture from which two walls extend outwards from the chamber to converge towards the can discharge nozzle and define a duct the centre plane of which is inclined to the centre plane of said mouthpiece, characterized in that the aerosol discharged by the can circulates within the chamber with a vortex flow.
PCT/EP1998/005592 1997-09-05 1998-09-03 Nozzle for use in mouth-inhaling for aerosol medicaments WO1999012596A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
UA2000031257U UA1383U (en) 1997-09-05 1998-03-09 AEROSOL NOZZLE
AU92661/98A AU9266198A (en) 1997-09-05 1998-09-03 Nozzle for use in mouth-inhaling for aerosol medicaments
ROA200000243A RO120953B1 (en) 1997-09-05 1998-09-03 Nozzle for aerosol medicament inhaling device
RU2000105401/20U RU16905U1 (en) 1997-09-05 1998-09-03 NOZZLE USED FOR ORAL INHALATION WITH MEDICINES AS AEROSOL

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BR7702049U BR7702049U (en) 1997-09-05 1997-09-05 Spray nozzle for use in an oral inhaler for aerosol medicines
BRMU7702049-9 1997-09-05

Publications (1)

Publication Number Publication Date
WO1999012596A1 true WO1999012596A1 (en) 1999-03-18

Family

ID=37199269

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/005592 WO1999012596A1 (en) 1997-09-05 1998-09-03 Nozzle for use in mouth-inhaling for aerosol medicaments

Country Status (7)

Country Link
AU (1) AU9266198A (en)
BR (1) BR7702049U (en)
PL (1) PL60085Y1 (en)
RO (1) RO120953B1 (en)
RU (1) RU16905U1 (en)
TR (1) TR200000588U1 (en)
WO (1) WO1999012596A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049350A1 (en) * 2000-01-07 2001-07-12 Chiesi Farmaceutici S.P.A. Aerosol inhaler
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
US6964759B2 (en) 2000-02-22 2005-11-15 Chiesi Farmaceutici S.P.A. Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
US6967017B1 (en) 1999-07-23 2005-11-22 Chiesi Farmaceutici S.P.A. Formulations of steroid solutions for inhalatory administration
US7018618B2 (en) 2000-05-22 2006-03-28 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
US7223381B2 (en) 1998-11-25 2007-05-29 Chiesi Farmaceutici S.P.A. Pressurised metered dose inhalers (MDI)
US7381402B2 (en) 2004-02-27 2008-06-03 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
US7696178B2 (en) 2001-07-02 2010-04-13 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
US9179691B2 (en) 2007-12-14 2015-11-10 Aerodesigns, Inc. Delivering aerosolizable food products
USD852408S1 (en) 2016-02-08 2019-06-25 Nicoventures Holdings Limited Electronic cigarette
US11123501B2 (en) 2016-03-24 2021-09-21 Nicoventures Holdings Limited Electronic vapor provision system
US11213638B2 (en) 2016-03-24 2022-01-04 Nicoventures Trading Limited Vapor provision system
US11241043B2 (en) 2016-03-24 2022-02-08 Nicoventures Trading Limited Vapor provision apparatus
US11452826B2 (en) 2016-03-24 2022-09-27 Nicoventures Trading Limited Mechanical connector for electronic vapor provision system
US11524823B2 (en) 2016-07-22 2022-12-13 Nicoventures Trading Limited Case for a vapor provision device

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128655A (en) * 1965-09-29 1968-10-02 Vantorex Ltd Improvements in or relating to aerosol dispensing apparatus
US3517667A (en) * 1967-09-21 1970-06-30 Pennwalt Corp Aerosolized inhalator dispenser
EP0475257A1 (en) 1990-09-13 1992-03-18 CHIESI FARMACEUTICI S.p.A. Device for mouth-inhaling aerosol medicaments
GB2276101A (en) * 1993-03-19 1994-09-21 Csb Moulds Ltd Spray nozzles for pharmaceutical inhalers
US5622162A (en) * 1991-03-05 1997-04-22 Aradigm Corporation Method and apparatus for releasing a controlled amount of aerosol medication over a selectable time interval

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128655A (en) * 1965-09-29 1968-10-02 Vantorex Ltd Improvements in or relating to aerosol dispensing apparatus
US3517667A (en) * 1967-09-21 1970-06-30 Pennwalt Corp Aerosolized inhalator dispenser
EP0475257A1 (en) 1990-09-13 1992-03-18 CHIESI FARMACEUTICI S.p.A. Device for mouth-inhaling aerosol medicaments
US5622162A (en) * 1991-03-05 1997-04-22 Aradigm Corporation Method and apparatus for releasing a controlled amount of aerosol medication over a selectable time interval
GB2276101A (en) * 1993-03-19 1994-09-21 Csb Moulds Ltd Spray nozzles for pharmaceutical inhalers

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223381B2 (en) 1998-11-25 2007-05-29 Chiesi Farmaceutici S.P.A. Pressurised metered dose inhalers (MDI)
US6967017B1 (en) 1999-07-23 2005-11-22 Chiesi Farmaceutici S.P.A. Formulations of steroid solutions for inhalatory administration
CZ303394B6 (en) * 2000-01-07 2012-08-29 Chiesi Farmaceutici S. P. A. Device intended for use with a pressure vessel for dispensing proportioned aerosols
WO2001049350A1 (en) * 2000-01-07 2001-07-12 Chiesi Farmaceutici S.P.A. Aerosol inhaler
US6964759B2 (en) 2000-02-22 2005-11-15 Chiesi Farmaceutici S.P.A. Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
US7018618B2 (en) 2000-05-22 2006-03-28 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
US7696178B2 (en) 2001-07-02 2010-04-13 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
US7939502B2 (en) 2001-07-02 2011-05-10 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
US8168598B2 (en) 2001-07-02 2012-05-01 Chiesi Farmaceutici S.P.A. Optimised formulation of tobramycin for aerosolization
WO2003053501A1 (en) 2001-12-21 2003-07-03 Chiesi Farmaceutici S.P.A. Metered dose inhaler
EP1321159A1 (en) 2001-12-21 2003-06-25 CHIESI FARMACEUTICI S.p.A. Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
US7381402B2 (en) 2004-02-27 2008-06-03 Chiesi Farmaceutici S.P.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
US9179691B2 (en) 2007-12-14 2015-11-10 Aerodesigns, Inc. Delivering aerosolizable food products
USD852408S1 (en) 2016-02-08 2019-06-25 Nicoventures Holdings Limited Electronic cigarette
US11123501B2 (en) 2016-03-24 2021-09-21 Nicoventures Holdings Limited Electronic vapor provision system
US11213638B2 (en) 2016-03-24 2022-01-04 Nicoventures Trading Limited Vapor provision system
US11241043B2 (en) 2016-03-24 2022-02-08 Nicoventures Trading Limited Vapor provision apparatus
US11452826B2 (en) 2016-03-24 2022-09-27 Nicoventures Trading Limited Mechanical connector for electronic vapor provision system
US11524823B2 (en) 2016-07-22 2022-12-13 Nicoventures Trading Limited Case for a vapor provision device

Also Published As

Publication number Publication date
PL60085Y1 (en) 2003-12-31
PL110712U1 (en) 2000-06-19
AU9266198A (en) 1999-03-29
TR200000588U1 (en) 2000-07-21
RU16905U1 (en) 2001-02-27
RO120953B1 (en) 2006-10-30
BR7702049U (en) 1999-09-14

Similar Documents

Publication Publication Date Title
EP0475257B1 (en) Device for mouth-inhaling aerosol medicaments
US5435301A (en) Powder inhaler having dispersing, discharge, and dwell-time chambers, along with an acceleration channel
US6367471B1 (en) Internal vortex mechanism for inhaler device
US6345617B1 (en) Aerosol medication delivery apparatus and system
US6575160B1 (en) Inhalation device
US5699789A (en) Dry powder inhaler
US6062214A (en) Inhaler for medicament
CA2377566C (en) Low spray force, low retention atomization system
WO1999012596A1 (en) Nozzle for use in mouth-inhaling for aerosol medicaments
EP1328310B1 (en) Dry powder inhaler
US20050263618A1 (en) Atomizer for dispensing liquids for medical purposes
US9216259B2 (en) Methods and apparatus for delivering aerosolized medication
JPH01501290A (en) inhaler
JPH08502904A (en) Low flow nebulizer, atomization method and device
CA2396273C (en) Aerosol inhaler
JP2009533104A (en) Metering device
JP2003531693A (en) Respirator spacer assembly
EP0774986B1 (en) Inhaler apparatus with optimisation chamber
FI90727B (en) Nozzle
CA2244576C (en) Inhalation device

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2000/00588

Country of ref document: TR

ENP Entry into the national phase

Ref document number: 2000 200000243

Country of ref document: RO

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: CA